TSBX - Turnstone Biologics Corp Qarzning balans kapitallashuviga nisbati

Qarzdorlikning kitob qiymatidagi kapitalizatsiya koeffitsiyentining tarixiy tendentsiyasi, bunda oxirgi ko'rsatkich 0.03 ni tashkil etadi, klinik sinovlarning tashqi CRO markazlariga topshirilganiga asoslangan. Turnstone Biologics (TSBX) noyob TIL limfotsitlar tanlovi orqali onkologiya sohasida narxlarni belgilash imkoniyatini izlamoqda. Ilmiy erkinlik va kompaniya aksiyalariga egalik qilish sababli viral platforma ekspertlaridan iborat jamoa shtatda saqlanmoqda.

TSBX Turnstone Biologics Corp: Qarzning balans kapitallashuviga nisbati 21.02.2024 - 24.08.2025 oraligʻida

Fundamental kuchning yuqori zaxiraga ega aksiyalarini tanlash qarzdorlik yuklamasini tahlil qilishdan boshlanadi. `dvsbcap_co` koeffitsiyenti kapitalning barcha majburiyatlarni qoplash qobiliyatini o'lchab, moliyaviy barqarorlikni yoki leveraj darajasini aniqlaydi. Turnstone Biologics (TSBX) uchun ushbu muvozanat qattiq o'smalarga qarshi TIL terapiyasi ishlab chiqilishini moliyalashtirishda hal qiluvchi ahamiyatga ega. Resurslarning optimal nisbati innovatsiyalarning rivojlanishini bankrotlik xavfisiz ta'minlaydi. Ushbu narx harakati kapital tuzilmasi tendentsiyasini, ya'ni qarzdorlikning kitob kapitalizatsiyasiga nisbatini aks ettiradi.

Turnstone Biologics raqobatchilari

ImmunityBio, Inc. - Balans kapitallashuviga qarzlar|immunocore.com - Qarzning balans qiymatiga nisbati|JANX (Janux Therapeutics, Inc.) - Qarzning balans kapitallashuviga nisbati|RCUS: Balans qiymatiga qarzlar|Zymeworks Corp (ZYME) - Qarzning balans kapitallashuviga nisbati|TNGX (Tango Therapeutics Corp) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati IOVA (Iovance Biotherapeutics)|Balans qiymatiga qarzlar immatics.com|XNCR: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Compass Therapeutics Inc CMPX|REPL: Qarzning balans qiymatiga nisbati|LYEL - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Innate Pharma S.A. (IPHA)|PYXS - Qarzning sof aktivlarga nisbati|cgen.com - Balans kapitallashuviga qarzlar|IOBT (IO Biotech Inc) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati STRO|Qarzning balans qiymatiga nisbati INKT|Qarzning balans kapitallashuviga nisbati HOWL (Werewolf Therapeutics)|Qarzning balans qiymatiga nisbati immixbio.com IMMX|Qarzning balans qiymatiga nisbati ALXO (ALX Oncology Holdings)|cuebiopharma.com - Balans kapitallashuviga qarzlar|PDS Biotechnology Corp (PDSB) - Qarzning balans kapitallashuviga nisbati|SONN: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati MAIA|Balans qiymatiga qarzlar liminatuspharma.com|LAVA Therapeutics NV - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati NextCure Inc (NXTC)|Qarzning balans qiymatiga nisbati Leap Therapeutics, Inc.|Qarzning balans kapitaliga nisbati intensitytherapeutics.com (INTS)|Balans kapitallashuviga qarzlar Sensei Biotherapeutics, Inc.|Qarzning sof aktivlarga nisbati therivabio.com TOVX|GRTS (Gritstone Bio) - Balans kapitallashuviga qarzlar|KA: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati NexImmune Corp NEXI|Vaccinex Inc (VCNX) - Qarzning sof aktivlarga nisbati|HARP (Harpoon Therapeutics) - Balans kapitallashuviga qarzlar